Increasing Prevalence of Cancer to Augment Growth of the Glycobiology Market

 

Glycobiology Market

Glycobiology is the study of the structure, function, and biology of carbohydrates, also called glycans. It is the general classification for carbohydrates covalently linked with other chemical species such as saccharides, lipids, peptides, and proteins. Polysaccharides and glycans play an important structural role in connective tissues. Glycobiology or glycomics find a wide variety of application in areas such as industrial applications, therapeutic application, diagnostic applications, and drug discovery and development. The growth of the glycobiology market is mainly driven by the increasing prevalence of cancer worldwide, as glycans impact invasion, angiogenesis, hematogenous metastasis, and tumor proliferation.

According to the International Agency for Research on Cancer (IARC), worldwide, one in five people develop cancer during their lifetime, and one in eight men and one in eleven women die from the disease. Moreover, according to National Cancer Institute, in 2020, around 1,806,590 new cases of cancer were expected to be diagnosed in the United States and around 606,520 people were expected to die from the disease. The most common type of cancer on the list is breast cancer, with 284,200 new cases expected in the United States in 2021. Thus, with the increasing prevalence of cancer, the demand for cancer therapeutics is also increasing. This in turn is expected to augment the growth of the glycobiology market.

For instance, in 2020, researchers from Universidade do Porto, Portugal, reported assessment of the role of O-glycan using glycoengineered gastric cancer models in the detection of CD44v9 by monoclonal antibodies. O-glycan truncation enhances cancer-related functions of CD44 in gastric cancer. Furthermore, increasing prevalence of HIV/AIDS is also expected to propel the glycobiology market growth. According to Joint United Nations Program on HIV/AIDS, in 20218, 37.9 million people were living with HIV, worldwide. The aforementioned factors are also expected to drive the glycobiology market growth.

Rising investments from both government and non-government organizations have enabled researchers to develop new glycobiology or glycomics tools, as there is a need for advanced analytical tools/methods to study pathogen and human glycobiology in disease and health. Hereafter, there has been an increase in proteomics and biomedical research, leading to the growth of the glycobiology market. For instance, in 2020, researchers from the University of Minho developed a neurocompatible strategy to image temporal distribution of glycoproteins during neuronal development using Cu-free click chemistry. This in turn is also expected to aid the glycobiology market growth.


Comments

Popular posts from this blog

Fitness Equipment Market is doing warm-ups to pull growth-rich opportunities from the growing obesity rates accompanied by the sedentary lifestyles

Pressure Bandages Market : Global Industry Analysis and Opportunity Assessment

Botanical and Plant Derived Drugs Market by Source,Dosage - Global Industry Analysis,Size,Share